NCT06845800

Brief Summary

This observational study aims to integrate anamnestic, clinical, and innovative neurophysiological data to assess their impact on the diagnosis and prognosis of patients with Disorders of Consciousness. The main questions it aims to answer are:

  • Is it possible to identify biomarkers with high diagnostic relevance for distinguishing subcategories of patients with Disorders of Consciousness?
  • Can biomarkers with potential medium- and long-term prognostic value be identified for each category of patients with Disorders of Consciousness? Participants will undergo an EEG examination during near-nerve stimulation of the median nerve. Clinical and anamnestic data will also be recorded and collected at follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2022

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

February 17, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 25, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2025

Completed
Last Updated

August 24, 2025

Status Verified

February 1, 2025

Enrollment Period

2.7 years

First QC Date

February 17, 2025

Last Update Submit

August 22, 2025

Conditions

Keywords

ElectroencephalographyNear-Nerve StimulationPrognosisDiagnosisNeurorehabilitationDisorder of Consciousness

Outcome Measures

Primary Outcomes (2)

  • Identification of Neurophysiological Diagnostic Biomarkers in Disorders of Consciousness

    Quantification of the Agreement Between Newly Proposed Neurophysiological Markers From Near-Nerve Stimulation Examinations and Disorders of Consciousness Classification Based on the Coma Recovery Scale-Revised (UWS, MCS-, MCS+)

    From enrollment to the baseline experimental session (within 7 days from enrollment)

  • Identification of Neurophysiological Prognostic Biomarkers in Disorders of Consciousness

    Quantification of Prognostic Prediction Accuracy of Newly Proposed Neurophysiological Markers From Near-Nerve Stimulation in Classifying Disorders of Consciousness Based on the Coma Recovery Scale - Revised (UWS, MCS-, MCS+, EMCS)

    From enrollment to the end of follow up at 6-months from baseline assessment

Study Arms (1)

Patients with Disorders of Consciousness admitted to the Intensive Rehabilitation Unit

Patients admitted with a Disorder of Consciousness to the Intensive Rehabilitation Unit (IRU) of Fondazione Don Carlo Gnocchi (Florence). * Age ≥ 18 years, both sexes; * Severe Acquired Brain Injury (ABI), regardless of etiology; * Patients with a severe alteration of consciousness due to severe ABI of various etiologies, including Cardiac Arrest, Traumatic Brain Injury, Cerebral Ischemia, or Hemorrhage; * Signed informed consent provided by a family member, caregiver, or legal guardian.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who were admitted with a Disorder of Consciousness to the Intensive Rehabilitation Unit (IRU) of Fondazione Don Carlo Gnocchi (Florence).

You may qualify if:

  • Age \> 18 years, both sexes;
  • Severe acquired brain injury (regardless of etiology);
  • Patients with severe alteration of consciousness state due to severe acquired brain injury of various etiologies (Cardiac Arrest, Traumatic Brain Injury, Cerebral Ischemia or Hemorrhage);
  • Informed consent signature by family member/caregiver/legal guardian.

You may not qualify if:

  • Time since the acute event greater than 3 months;
  • Previous neurological diseases;
  • Previous acute brain injuries, psychiatric disorders, neurodegenerative diseases, neoplasms, severe systemic diseases;
  • Modified Barthel Index pre-event \< 50;
  • Unstable medical conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione Don Carlo Gnocchi

Florence, FI, 50143, Italy

Location

Related Publications (3)

  • Vallbo AB. Microneurography: how it started and how it works. J Neurophysiol. 2018 Sep 1;120(3):1415-1427. doi: 10.1152/jn.00933.2017. Epub 2018 Jun 20.

    PMID: 29924706BACKGROUND
  • Mano T, Iwase S, Toma S. Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans. Clin Neurophysiol. 2006 Nov;117(11):2357-84. doi: 10.1016/j.clinph.2006.06.002. Epub 2006 Aug 10.

    PMID: 16904937BACKGROUND
  • Hakiki B, Donnini I, Romoli AM, Draghi F, Maccanti D, Grippo A, Scarpino M, Maiorelli A, Sterpu R, Atzori T, Mannini A, Campagnini S, Bagnoli S, Ingannato A, Nacmias B, De Bellis F, Estraneo A, Carli V, Pasqualone E, Comanducci A, Navarro J, Carrozza MC, Macchi C, Cecchi F. Clinical, Neurophysiological, and Genetic Predictors of Recovery in Patients With Severe Acquired Brain Injuries (PRABI): A Study Protocol for a Longitudinal Observational Study. Front Neurol. 2022 Feb 28;13:711312. doi: 10.3389/fneur.2022.711312. eCollection 2022.

    PMID: 35295839BACKGROUND

MeSH Terms

Conditions

DiseaseConsciousness Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2025

First Posted

February 25, 2025

Study Start

July 21, 2022

Primary Completion

March 28, 2025

Study Completion

March 28, 2025

Last Updated

August 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Upon publication of results, anonymized data and analysis code will be shared to ensure reproducibility. Zenodo and GitHub repositories will be created.

Shared Documents
SAP, ANALYTIC CODE
Time Frame
Upon publication of results
Access Criteria
Data and code will be available for research purposes upon request to authors.

Locations